A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glaltiramer Acetate to Either Agent Alone in Patients with Relapsing Remitting multiple Sclerosis (CombiRx-PhaseIII)

Grant

Date/time Interval

  • December 1, 2004 - November 30, 2012
  • Total Award Amount

  • 399922.00
  • Direct Costs

  • 276762.00
  • Sponsor Award Id

  • Contributor

  • Bashir, Khurram   Principal Investigator